CA
NZ
UK
AU
IND
US
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) awarded President and Head of R&D Miralles Gines Diego 45,000 shares at $0 per share on Sep. 9, 2026. The transaction was recorded under code A, an award or grant classification.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) awarded Chief Medical Officer Banerjee Subhashis 30,000 shares at $0 per share on September 9, 2026. The same date also brought an award of 85,000 derivative securities.
AtaiBeckley Inc. (NASDAQ: ATAI) Chief Medical Officer Craig Kevin James disposed of 8,437 shares on 11 September 2026, leaving him with zero shares.
AtaiBeckley Inc. (NASDAQ: ATAI) shares totaling 216,442 were disposed of by Rao Srinivas across two transactions. His reported share holdings were zero after the transactions.
Barinthus Biotherapeutics plc. saw Oxford Science Enterprises plc transact 8,797,770 shares at $0.11 per share.
Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares were sold by Sun Nelson in two transactions involving 76,754 shares. The reported sales leave Nelson with a stated post-transaction holding in the company’s shares.
ACADIA PHARMACEUTICALS INC (NASDAQ: ACAD) must notify stockholders about a proposed settlement in case 3:23-cv-02293 after a federal court granted preliminary approval on August 24, 2026. If approved, the resolution would affect holders’ rights to challenge the settlement and pursue released claims.
Currie Harriss T received 141,372 shares of AdaptHealth Corp (NASDAQ: AHCO). on 9 September 2026, becoming the holder of 141,372 shares. Harriss is AdaptHealth’s chief financial officer.
Investors approved a consolidation and split adjustment covering outstanding pre-IPO warrants. The resolutions were approved at a Special and Extraordinary General Shareholders’ Meeting, where shareholders backed every proposal submitted for consideration. Chief Executive Officer Tim Knotnerus said their experience would support the company as …
Alignment Healthcare, Inc. (NASDAQ: ALHC) CEO Kao John E sold 557,870 shares across two transactions, with prices ranging from $12.68 to $12.96 per share. The reported ownership figure after the sales was 1,223,473 shares.
Please wait processing your request...